1. Home
  2. PWP vs MDXG Comparison

PWP vs MDXG Comparison

Compare PWP & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perella Weinberg Partners

PWP

Perella Weinberg Partners

HOLD

Current Price

$21.61

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

N/A

Current Price

$5.38

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PWP
MDXG
Founded
2006
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PWP
MDXG
Price
$21.61
$5.38
Analyst Decision
Hold
Strong Buy
Analyst Count
3
3
Target Price
$22.33
$10.67
AVG Volume (30 Days)
909.3K
948.6K
Earning Date
02-06-2026
02-25-2026
Dividend Yield
1.30%
N/A
EPS Growth
N/A
N/A
EPS
0.70
0.27
Revenue
$757,415,000.00
$393,442,000.00
Revenue This Year
N/A
$19.13
Revenue Next Year
$40.58
$2.11
P/E Ratio
$31.07
$19.96
Revenue Growth
N/A
14.77
52 Week Low
$14.12
$5.13
52 Week High
$27.03
$9.36

Technical Indicators

Market Signals
Indicator
PWP
MDXG
Relative Strength Index (RSI) 72.49 20.58
Support Level $20.89 $5.15
Resistance Level $22.27 $6.50
Average True Range (ATR) 0.89 0.22
MACD 0.40 -0.11
Stochastic Oscillator 89.51 9.55

Price Performance

Historical Comparison
PWP
MDXG

About PWP Perella Weinberg Partners

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: